Narayana Hrudayalaya Limited Share Price & Stock Analysis

Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services.

Key Metrics

Current Price₹1,934.20
Market Cap₹39,284 Cr
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Facilities > Assisted Living Facilities and Services
P/E Ratio48.5
Return on Equity19.84%
52-Week Range₹1,589.00 – ₹2,370.20
Beta (1Y)0.41
Dividend Yield0.23%

Business Segments

1. Medical and Healthcare Related Services-95.7% 2. Others-4.8%

Peer Companies

Frequently Asked Questions

What is the current share price of Narayana Hrudayalaya Limited?

Narayana Hrudayalaya Limited is trading at ₹1,934.20, with a market capitalisation of ₹39,284 Cr.

Which sector does Narayana Hrudayalaya Limited belong to?

Narayana Hrudayalaya Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Assisted Living Facilities and Services).

What are the key financial ratios of Narayana Hrudayalaya Limited?

Narayana Hrudayalaya Limited has a P/E of 48.5 and a return on equity of 19.84%.